ribavirin has been researched along with Pulmonary Hypertension in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diego, R; Giampaolo, Q; Marco, R; Sara, B; Vasilij Benatti, S | 1 |
| Benhaourech, S; Borentain, P; Bregigeon, S; Colson, P; Darque, A; Gaubert, MR; Habib, G; Laugier, D; Maille, B; Renard, S; Salaun, E | 1 |
| Aichelburg, MC; Breitenecker, F; Ferlitsch, A; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Schmied, B; Sieghart, W; Trauner, M | 1 |
| Custer, JR; Khan, AS; Meliones, JN; Moler, FW; Palmisano, J; Shope, TC | 1 |
4 other study(ies) available for ribavirin and Pulmonary Hypertension
| Article | Year |
|---|---|
Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients.
Topics: Adult; Antiviral Agents; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension, Pulmonary; Interferon-alpha; Lung Diseases, Interstitial; Male; Middle Aged; Ribavirin | 2014 |
Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir.
Topics: Antiviral Agents; Carbamates; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension, Portal; Hypertension, Pulmonary; Imidazoles; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Valine | 2016 |
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Topics: Adult; Anti-Retroviral Agents; Cardiac Output; CD4 Lymphocyte Count; Coinfection; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Hypertension, Portal; Hypertension, Pulmonary; Interferon-alpha; Liver; Liver Cirrhosis; Lung; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prospective Studies; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Treatment Outcome; Viremia | 2012 |
Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience.
Topics: Academic Medical Centers; Cohort Studies; Heart Defects, Congenital; Hospitals, Pediatric; Humans; Hypertension, Pulmonary; Infant; Infant Mortality; Length of Stay; Michigan; Outcome Assessment, Health Care; Prognosis; Respiration, Artificial; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Ribavirin; Risk Factors | 1992 |